.

ISSN 2063-5346
For urgent queries please contact : +918130348310

QBD APPROACH TO ANALYTICAL RP- HPLC METHOD DEVELOPMENT AND VALIDATION OF ERLOTINIB IN PHARMACEUTICAL DOSAGE FORM

Main Article Content

Ronald Darwin1*, Veer Sujata Umakant2
» doi: 10.48047/ecb/2022.11.12.140

Abstract

By using desired and specified requirements, quality by design (QbD) aims to attain a certain predictable quality. Understanding components and the impacts of their interactions through a chosen set of tests is a highly helpful QbD component. The current work outlines the creation of a thorough science- and risk-based HPLC technique for the analysis of Erlotinib active pharmaceutical ingredient (API) utilizing a quality by design methodology

Article Details